Company news

CNS Pharmaceuticals, Inc. news in 2026

CNS Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

September 1, 2026

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

August 27, 2026

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

August 12, 2026

CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Oversubscribed $22.5M Financing, Growth Strategy in Investor Presentation

June 8, 2026

CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment

June 8, 2026

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

May 20, 2026

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

May 13, 2026

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

May 3, 2026

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

March 10, 2026

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

March 2, 2026

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

February 17, 2026

CNS Pharmaceuticals Issues Letter to Shareholders

January 27, 2026

Decks in 2026